Clinical trial
A Phase II Trial of High-Dose Ascorbate in Stage IV Non-Small Cell Lung Cancer
NCT02420314 is registered in ClinicalTrials.gov with Joseph J. Cullen, MD, FACS as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase II Trial of High-Dose Ascorbate in Stage IV Non-Small Cell Lung Cancer
- Lead sponsor
- Joseph J. Cullen, MD, FACS
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- April 30, 2015
- Completion date
- August 27, 2022
- Enrollment
- 55 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.